@biotechnetworks.bsky.social
bionetworks Trending: Adjunct Faculty – Advanced Molecular Biology Techniques – Remote https://zpr.io/ZdhePyiUS6h6
December 8, 2025 at 11:25 PM
bionetworks Trending: Adjunct Faculty – Advanced Molecular Biology Techniques – Remote https://zpr.io/ZdhePyiUS6h6
BCBN Trending: Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025 https://zpr.io/m5Xj4DtNLL99
December 8, 2025 at 11:25 PM
BCBN Trending: Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025 https://zpr.io/m5Xj4DtNLL99
BCBN Trending: Flagship AI spinout lays off employees amid reorganization https://zpr.io/ehQtsrMKcwH7
December 8, 2025 at 11:25 PM
BCBN Trending: Flagship AI spinout lays off employees amid reorganization https://zpr.io/ehQtsrMKcwH7
bionetworks Trending: Associate Director/Director, Medical Communications – Remote https://zpr.io/cTmZxyFzmUtr
December 8, 2025 at 11:25 PM
bionetworks Trending: Associate Director/Director, Medical Communications – Remote https://zpr.io/cTmZxyFzmUtr
BCBN Trending: Dyne Therapeutics to Host Investor Conference Call and Webcast to Review Topline Results from Registrational Expansion Cohort (REC) of DELIVER Clinical Trial of Z-Rostudirsen (DYNE-251) in Duchenne Muscular Dystrophy; Tomorrow, December 8 at 8:00 a.m. ET https://zpr.io/tPfGnCptSyjM
December 8, 2025 at 6:35 PM
BCBN Trending: Dyne Therapeutics to Host Investor Conference Call and Webcast to Review Topline Results from Registrational Expansion Cohort (REC) of DELIVER Clinical Trial of Z-Rostudirsen (DYNE-251) in Duchenne Muscular Dystrophy; Tomorrow, December 8 at 8:00 a.m. ET https://zpr.io/tPfGnCptSyjM
SDBN Trending: MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND https://zpr.io/KgKCkDAe2iRR
December 8, 2025 at 6:35 PM
SDBN Trending: MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND https://zpr.io/KgKCkDAe2iRR
SDBN Trending: Lawsuit DEADLINE: Investors who purchased over $100,000 worth of shares of Skye Bioscience, Inc. (NASDAQ: SKYE) between Nov. 2024 and Oct. 2025 should contact the Shareholders Foundation https://zpr.io/4sMEArz3KgSK
December 8, 2025 at 6:35 PM
SDBN Trending: Lawsuit DEADLINE: Investors who purchased over $100,000 worth of shares of Skye Bioscience, Inc. (NASDAQ: SKYE) between Nov. 2024 and Oct. 2025 should contact the Shareholders Foundation https://zpr.io/4sMEArz3KgSK
BCBN Trending: Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting https://zpr.io/52UXB5b5HkFW
December 8, 2025 at 3:49 PM
BCBN Trending: Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting https://zpr.io/52UXB5b5HkFW
PNBN Trending: #ASH25: As one door closes for Regeneron’s lymphoma bispecific, another reopens https://zpr.io/ZEJjQYHwmKqq
December 8, 2025 at 3:49 PM
PNBN Trending: #ASH25: As one door closes for Regeneron’s lymphoma bispecific, another reopens https://zpr.io/ZEJjQYHwmKqq
PNBN Trending: ASH: Pfizer, aiming to level the hemophilia playing field, trots out new Hympavzi data https://zpr.io/Q79EHvQC76Vr
December 8, 2025 at 3:49 PM
PNBN Trending: ASH: Pfizer, aiming to level the hemophilia playing field, trots out new Hympavzi data https://zpr.io/Q79EHvQC76Vr
bionetworks Trending: Biology Tutor – Remote https://zpr.io/t3HuhSymCAF3
December 8, 2025 at 3:49 PM
bionetworks Trending: Biology Tutor – Remote https://zpr.io/t3HuhSymCAF3
bionetworks Trending: MEDITECH SUPPORT ANALYST – Remote https://zpr.io/2QucfhiN86dv
December 8, 2025 at 3:49 PM
bionetworks Trending: MEDITECH SUPPORT ANALYST – Remote https://zpr.io/2QucfhiN86dv
bionetworks Trending: Director, Quality Assurance (Quality Systems), Remote – Fort Lauderdale, FL https://zpr.io/VjVSrWjRpUh5
December 7, 2025 at 1:24 PM
bionetworks Trending: Director, Quality Assurance (Quality Systems), Remote – Fort Lauderdale, FL https://zpr.io/VjVSrWjRpUh5
bionetworks Trending: Head of Technology Development – Remote https://zpr.io/ZwKDyiB4s5RL
December 7, 2025 at 1:24 PM
bionetworks Trending: Head of Technology Development – Remote https://zpr.io/ZwKDyiB4s5RL
LABN Trending: The Los Angeles Sports & Entertainment Commission (LASEC) Names Amgen as Official Biotech Partner and Los Angeles World Cup 2026 Host City Supporter Ahead of FIFA World Cup 2026™ https://zpr.io/MKAWq5j4QHNb
December 7, 2025 at 3:13 AM
LABN Trending: The Los Angeles Sports & Entertainment Commission (LASEC) Names Amgen as Official Biotech Partner and Los Angeles World Cup 2026 Host City Supporter Ahead of FIFA World Cup 2026™ https://zpr.io/MKAWq5j4QHNb
SDBN Trending: UC San Diego’s Accelerating Innovation to Market Program Announces 2026 Cohort https://zpr.io/yvv2hV2cpqDV
December 7, 2025 at 3:13 AM
SDBN Trending: UC San Diego’s Accelerating Innovation to Market Program Announces 2026 Cohort https://zpr.io/yvv2hV2cpqDV
BCBN Trending: GSK takes over entire building in Cambridge https://zpr.io/GMPr9nFjwGke
December 7, 2025 at 3:13 AM
BCBN Trending: GSK takes over entire building in Cambridge https://zpr.io/GMPr9nFjwGke
TXBN Trending: Avance Biosciences opens 75K-SF biomanufacturing facility in northwest Houston https://zpr.io/fgQXux8wfzPz
December 7, 2025 at 3:13 AM
TXBN Trending: Avance Biosciences opens 75K-SF biomanufacturing facility in northwest Houston https://zpr.io/fgQXux8wfzPz
UCBN Trending: Boulder diagnostics co. bought by Austin biotech giant in $450M deal https://zpr.io/Qh6vFn4mKE8E
December 7, 2025 at 3:13 AM
UCBN Trending: Boulder diagnostics co. bought by Austin biotech giant in $450M deal https://zpr.io/Qh6vFn4mKE8E
SDBN Trending: Strength-Based ADHD Testing for Teens and Adults Who Were Never Diagnosed: Validation, Understanding, and New Possibilities https://zpr.io/bUeBwmht842c
December 7, 2025 at 3:13 AM
SDBN Trending: Strength-Based ADHD Testing for Teens and Adults Who Were Never Diagnosed: Validation, Understanding, and New Possibilities https://zpr.io/bUeBwmht842c
bionetworks Trending: Principal Scientist, Preclinical Toxicology – Remote https://zpr.io/dUrNcLiJpZrP
December 7, 2025 at 3:13 AM
bionetworks Trending: Principal Scientist, Preclinical Toxicology – Remote https://zpr.io/dUrNcLiJpZrP
bionetworks Trending: Associate Director, US Medical Review – Remote https://zpr.io/ERT39rD3a7Wc
December 6, 2025 at 6:50 AM
bionetworks Trending: Associate Director, US Medical Review – Remote https://zpr.io/ERT39rD3a7Wc
bionetworks Trending: Bioinformatics Engineer – Remote https://zpr.io/iWDgx7zatjxV
December 6, 2025 at 6:50 AM
bionetworks Trending: Bioinformatics Engineer – Remote https://zpr.io/iWDgx7zatjxV
bionetworks Trending: Research Scientist / Bioinformatics Innovator – Remote https://zpr.io/MAzkN4tAAAfy
December 5, 2025 at 6:30 PM
bionetworks Trending: Research Scientist / Bioinformatics Innovator – Remote https://zpr.io/MAzkN4tAAAfy
UCBN Trending: Vice President Dick Cheney’s Life Followed the Arc of the Biggest Breakthroughs in Cardiovascular Medicine https://zpr.io/Tn9KdhxtWsbF
December 5, 2025 at 4:12 PM
UCBN Trending: Vice President Dick Cheney’s Life Followed the Arc of the Biggest Breakthroughs in Cardiovascular Medicine https://zpr.io/Tn9KdhxtWsbF